Tg Therapeutics (TGTX) EBITDA (2011 - 2026)
Tg Therapeutics' EBITDA was $21.73 million in Q2 2026, down 37.7% from $34.86 million a year earlier and down 37.6% from the prior quarter.
Powered by 
Analysis
Tg Therapeutics (TGTX) EBITDA (2011 - 2026) Analysis & Trends
On a trailing twelve-month basis, Tg Therapeutics' EBITDA was $136.45 million through Jun 30, 2026, up 58.9% year-over-year; for FY2025, it came in at $123.38 million, up 193.8% from FY2024.
- In earlier years, EBITDA was $42 million in FY2024 (+101.5%), $20.84 million in FY2023, -$217.8 million in FY2022 and -$344.28 million in FY2021.
- The Q2 2026 figure marks the lowest quarterly EBITDA since Q1 2025.
- Compared with a year earlier, EBITDA was higher in four of the last six quarters, with growth averaging 112.7%.
- Per Business Quant data, TGTX's EBITDA in the three quarters before Q2 2026 was $34.83 million (Q1 2026), $50.52 million (Q4 2025) and $29.38 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 9.10 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 8.33 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 999.00 Mn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 5.09 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 4.63 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -9.70 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 5.89 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 1.30 Bn |
| 10 | Tg Therapeutics | 8.60 Bn | 7.99 Bn | 199.14 Mn | 21.73 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 21.73 Mn |
| Mar 31, 2026 | 34.83 Mn |
| Dec 31, 2025 | 50.52 Mn |
| Sep 30, 2025 | 29.38 Mn |
| Jun 30, 2025 | 34.86 Mn |
| Mar 31, 2025 | 8.63 Mn |
| Dec 31, 2024 | 29.96 Mn |
| Sep 30, 2024 | 12.45 Mn |
| Jun 30, 2024 | 8.84 Mn |
| Mar 31, 2024 | -9.24 Mn |
| Dec 31, 2023 | -12.45 Mn |
| Sep 30, 2023 | 114.91 Mn |
| Jun 30, 2023 | -44.59 Mn |
| Mar 31, 2023 | -36.87 Mn |
| Dec 31, 2022 | -77.41 Mn |
| Sep 30, 2022 | -34.83 Mn |
| Jun 30, 2022 | -38.81 Mn |
| Mar 31, 2022 | -66.74 Mn |
| Dec 31, 2021 | -92.81 Mn |
| Sep 30, 2021 | -85.00 Mn |
API Access
Tg Therapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=TGTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "TGTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=TGTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();